Research from the John P. Hussman Institute for Human Genomics at the University of Miami Miller School of Medicine again supports the importance of structural variation in autism spectrum disorders.
A team of researchers led by Claes Wahlestedt, M.D., Ph.D., the Miller School’s associate dean for therapeutic innovation, has pinpointed a “master” regulatory molecule in the brain that is altered in people with schizophrenia. The finding could facilitate the development of better drugs for the debilitating psychiatric disorder that affects an estimated one percent of the world’s population.
University of Miami researchers have identified a genetic variant linked to a rare form of paraplegia in a paper titled “Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 2,” published online January 10 in the Journal of Clinical Investigation.
Visit us on the Web
